Most adverse events related to the use of
orlistat Xenical® result from its own action on the digestive system, which is to decrease the absorption of part of the fat contained in food.
If you have symptoms related to the digestive system, they will usually be mild and will occur at the beginning of treatment, disappearing after a short period of time.
The intensity of these effects may increase after eating high-fat meals, improving with the continuity of treatment and following the recommended diet.
The adverse reactions (first year of treatment) listed below are based on adverse events that occurred frequently> 2% and incidence = 1% compared to placebo in one- and two-year clinical studies:
Very common reactions (occur in> 10% of patients using this medication): oily leaks or bowel movements, flatulence (accumulation of gases in the intestine) with oily leaks, urgency to evacuate, increased bowel movements, abdominal discomfort / pain, gas, stools fluids, upper respiratory tract infections (such as a cold and sore throat), flu, headache and hypoglycemia (low blood sugar).
Common reactions (occur between 1% and 10% of patients using this medication): loss of bowel control, soft stools, rectal discomfort / pain, dental or gum disorders, lower respiratory tract infections (such as tracheobronchitis or bronchopneumonia), irregularities menstrual periods, anxiety, fatigue, urinary tract infection and bloating.
The only adverse reactions observed with frequency> 2% and incidence = 1% compared to placebo in obese patients with type 2 diabetes were hypoglycemia (low blood sugar) and bloating.
In a four-year clinical study, the general pattern of adverse event distribution was similar to that reported in the one- and two-year studies. Over the four years of study this
remedio para emagrecer, a gradual reduction in the total incidence of related gastrointestinal adverse events that occurred in the first year was observed.
Post-marketing
Rare cases of hypersensitivity have been reported i Dieta 10. The main clinical symptoms were itching, rash, hives (red spots with sharp edges, very itchy, which change places in the body), angioedema (swelling usually in the eyelids, lips and throat, which can make breathing difficult), bronchospasm (narrowing of the bronchi that makes it difficult for air to pass, causing shortness of breath and wheezing) and anaphylaxis (very severe hypersensitivity reaction, accompanied by difficulty breathing). Very rare cases of bullous rash, increased liver enzymes (substances that indicate loss of liver function) and alkaline phosphatase (blood test that detects changes in the flow of bile) and exceptional cases of severe liver damage, some resulting in liver transplantation or death have been reported. No causal relationship or mechanism of inflammation in the liver has been established with orlistate
Xenical® therapy.
There have been reports of changes in blood tests related to blood clotting and uncontrolled treatment with anticoagulants in patients treated concomitantly with Xenical® and anticoagulants.
Seizures have been reported in patients treated with Xenical® and antiepileptic drugs at the same time (see item Main drug interactions).
Cases of hyperoxaluria (urinary loss of oxalate crystals) and oxalate nephropathy (loss of kidney function) have been reported.
Inform your doctor, dentist or pharmacist about the appearance of undesirable reactions due to the use of the medication. Also inform the company through its customer service
https://dieta-10.com Dieta 10.
Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The news site hosting this press release is not associated with Xenical®. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.
About Dieta 10